FDA Approves Shorter Infusion Time for MS Therapy Ocrevus & How Lucy the Dog Changed My Life

Jan 18, 12:00 AM
Multiple Sclerosis News Today’s columnist, Jenn Powell, discusses the FDA approval of a shorter infusion time for the MS therapy Ocrevus.
Plus, Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, reads Jessie Ace’s column, DISabled to ENabled, on the things people say when you tell them about your multiple sclerosis diagnosis.
Treatment for Relapsing MS Progression | MAYZENT® (siponimod)
Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.

Are you interested in learning more about multiple sclerosis? If so, please visit:
To join in on conversations regarding multiple sclerosis, please visit: